• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Measurable Residual Disease Before Reduced-Intensity Allogeneic Transplantation in Patients With Myeloid Malignancy.

作者信息

Gui Gege, Dillon Laura W, Hourigan Christopher S

机构信息

Gege Gui, ScM, Laura W. Dillon, PhD, and ChristopherS. Hourigan, DM, DPhil, Laboratory of Myeloid Malignancy, Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, MD.

出版信息

J Clin Oncol. 2021 Jul 20;39(21):2413-2415. doi: 10.1200/JCO.21.00255. Epub 2021 May 5.

DOI:10.1200/JCO.21.00255
PMID:33950704
Abstract
摘要

相似文献

1
Measurable Residual Disease Before Reduced-Intensity Allogeneic Transplantation in Patients With Myeloid Malignancy.髓系恶性肿瘤患者在减低强度异基因移植前的可测量残留病
J Clin Oncol. 2021 Jul 20;39(21):2413-2415. doi: 10.1200/JCO.21.00255. Epub 2021 May 5.
2
WT1 Measurable Residual Disease Assay in Patients With Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation: Optimal Time Points, Thresholds, and Candidates.WT1 可测量残留病检测在接受异基因造血干细胞移植的急性髓系白血病患者中的应用：最佳时间点、阈值和候选者。
Biol Blood Marrow Transplant. 2019 Oct;25(10):1925-1932. doi: 10.1016/j.bbmt.2019.05.033. Epub 2019 Jun 4.
3
Interferon-α Is Effective for Treatment of Minimal Residual Disease in Patients with t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Registry Study.干扰素-α 对异基因造血干细胞移植后 t(8;21) 急性髓系白血病患者微小残留病的治疗有效：一项前瞻性登记研究的结果。
Oncologist. 2018 Nov;23(11):1349-1357. doi: 10.1634/theoncologist.2017-0692. Epub 2018 Aug 3.
4
Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: A registry analysis of 2292 patients by the Acute Leukemia Working Party European Society of Blood and Marrow Transplantation.可测量残留疾病、调理方案强度和年龄可预测首次缓解的急性髓系白血病患者接受异基因造血细胞移植的结果：欧洲血液和骨髓移植学会急性白血病工作组对 2292 例患者的注册分析。
Am J Hematol. 2018 Sep;93(9):1142-1152. doi: 10.1002/ajh.25211. Epub 2018 Aug 15.
5
Sequential reduced-intensity chemotherapy for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia with rare cytogenetic abnormalities transformed from Fanconi anemia.序贯减低剂量化疗用于范可尼贫血转化的伴有罕见细胞遗传学异常的急性髓系白血病患者的异基因造血干细胞移植
Pediatr Int. 2018 Sep;60(9):893-894. doi: 10.1111/ped.13648.
6
Time-to-Event Ratio to Predict Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation?用于预测接受异基因造血细胞移植的急性髓系白血病患者预后的事件发生时间比？
Biol Blood Marrow Transplant. 2017 Oct;23(10):1804-1808. doi: 10.1016/j.bbmt.2017.06.016. Epub 2017 Jul 5.
7
Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation.在减低强度或非清髓性异基因干细胞移植前，急性髓系白血病患者缓解和可测量残留病状态的预后相关性。
Blood Cancer J. 2021 Apr 29;11(4):80. doi: 10.1038/s41408-021-00471-x.
8
FLT3 inhibitor based induction and allogeneic stem cell transplant in complete remission 1 improve outcomes in patients with newly diagnosed Acute Myeloid Leukemia with very low FLT3 allelic burden.基于FLT3抑制剂的诱导治疗及完全缓解1期的异基因干细胞移植可改善新诊断的FLT3等位基因负担极低的急性髓系白血病患者的预后。
Am J Hematol. 2021 Aug 1;96(8):E275-E279. doi: 10.1002/ajh.26202. Epub 2021 May 8.
9
The impact of minimal residual disease prior to unmanipulated haploidentical hematopoietic stem cell transplantation in patients with acute myeloid leukemia in complete remission.完全缓解的急性髓系白血病患者在未处理的单倍体相合造血干细胞移植前微小残留病的影响。
Leuk Lymphoma. 2017 May;58(5):1135-1143. doi: 10.1080/10428194.2016.1239264. Epub 2016 Oct 12.
10
Allogeneic hematopoietic cell transplantation with sequential conditioning regimen in relapsed refractory acute myeloid leukemia.采用序贯预处理方案的异基因造血细胞移植治疗复发难治性急性髓系白血病。
Bone Marrow Transplant. 2024 Aug;59(8):1199-1201. doi: 10.1038/s41409-024-02310-6. Epub 2024 May 22.

引用本文的文献

1
Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine.后基因组时代的骨髓增生异常综合征及精准医学的未来展望
Cancers (Basel). 2021 Jun 30;13(13):3296. doi: 10.3390/cancers13133296.